Trends in antibiotic use among outpatients in New Delhi, India by Kotwani, Anita & Holloway, Kathleen
RESEARCH ARTICLE Open Access
Trends in antibiotic use among outpatients in
New Delhi, India
Anita Kotwani
1* and Kathleen Holloway
2
Abstract
Background: The overall volume of antibiotic consumption in the community is one of the foremost causes of
antimicrobial resistance. There is much ad-hoc information about the inappropriate consumption of antibiotics,
over-the-counter availability, and inadequate dosage but there is very little actual evidence of community practices.
Methods: This study surveyed antibiotic use in the community (December 2007-November 2008) using the
established methodology of patient exit interviews at three types of facilities: 20 private retail pharmacies, 10 public
sector facilities, and 20 private clinics to obtain a complete picture of community antibiotic use over a year. The
Anatomical Therapeutic Chemical (ATC) classification and the Defined Daily Dose (DDD) measurement units were
assigned to the data. Antibiotic use was measured as DDD/1000 patients visiting the facility and also as percent of
patients receiving an antibiotic.
Results: During the data collection period, 17995, 9205, and 5922 patients visiting private retail pharmacies, public
facilities and private clinics, respectively, were included in our study. 39% of the patients attending private retail
pharmacies and public facilities and 43% of patients visiting private clinics were prescribed at least one antibiotic.
Consumption patterns of antibiotics were similar at private retail pharmacies and private clinics where
fluoroquinolones, cephalosporins, and extended spectrum penicillins were the three most commonly prescribed
groups of antibiotics. At public facilities, there was a more even use of all the major antibiotic groups including
penicillins, fluoroquinolones, macrolides, cephalosporins, tetracyclines, and cotrimoxazole. Newer members from
each class of antibiotics were prescribed. Not much seasonal variation was seen although slightly higher
consumption of some antibiotics in winter and slightly higher consumption of fluoroquinolones during the rainy
season were observed.
Conclusions: A very high consumption of antibiotics was observed in both public and private sector outpatients.
There was a high use of broad spectrum and newer antibiotics in the community. Suitable and sustainable
interventions should be implemented to promote rational use of antibiotics that will help in decreasing the
menace of antibiotic resistance.
Background
The current worldwide increase in antimicrobial resis-
tance (AMR) and, simultaneously, the downward trend
in the development of new antibiotics have serious public
health and economic implications. The increased resis-
tance is a result of many factors, but the foremost cause
is the overall volume of antibiotic consumption. About
80% of antibiotics are used in the community and
the rest are used in hospitals [1,2]. It is estimated that
20-50% of all antibiotics use is inappropriate, resulting in
an increased risk of side effects, higher costs and higher
rates of AMR in community pathogens [3]. Detailed
surveillance of antibiotic use in the community is one
strategy to guide and control antibiotic overuse and
misuse. In a number of developed countries, extensive
surveillance programmes have been developed to study
patterns of AMR and antibiotic use [4-6]. However, the
problem of AMR has received relatively little recognition
in developing countries and the ability to undertake
extensive surveillance is lacking in resource-constrained
settings. Thus, there is a lack of community-based data-
bases on AMR and antibiotic use in developing countries.
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from private retail pharmacies without prescription and
pharmacists also advise and dispense antibiotics to
patients [7].
In collaboration with the World Health Organization
(WHO) a pilot project was conducted in New Delhi, India
(2002-2005) [8] and elsewhere [9] to develop validated
reproducible and sustainable surveillance methodologies
to quantify antimicrobial resistance and antibiotic use in
the community. The pilot project conducted by us in New
Delhi, India, utilized the same methodology as a previous
study that monitored antibiotic use in the community
through patient exit interviews at private retail pharmacies
[8]. This study, conducted during December 2007 -
November 2008, expanded the established methodology of
exiting patient interviews to a detailed community surveil-
lance of antibiotic use in three types of facilities: private
retail pharmacies, public sector facilities, and private
clinics. The primary aim of this study was to determine
the pattern and consumption of antibiotics at the commu-
nity level in the public and private sectors over one year.
Methods
Surveillance of antibiotic use was done by collecting
data from four municipal wards (residential localities) of
New Delhi, India. The study was done in conjunction
with another study (not described here) to measure the
antimicrobial resistance pattern for the OPD patients of
a private tertiary care hospital located in West Delhi.
Hence, the antibiotic use data was collected from four
municipal wards around this hospital - the same 4
wards as used in the previous study in private retail
pharmacies [8]. The four areas were - Rajinder Nagar,
Patel Nagar, Karol Bagh and Rajouri Garden.
Settings and Facility selection
Both the public and private sectors were included in the
survey. Medicines are provided free of charge to patients
in public sector facilities but must be paid for in private
sector facilities. In order to get a complete picture of
antibiotic use in the community, three different types of
facilities were chosen:
1. Public sector - All 10 facilities under the Govern-
ment of National Capital Territory of Delhi (GNCT
Delhi) in our catchment area were enrolled for the sur-
vey. The facilities were 8 dispensaries (Primary care
facility) and 2 hospitals (Secondary care level);
2. Private retail pharmacies - A total of 185 licensed
private retail shops were located in the four chosen
municipal wards from which 20 well-stocked, private
retail shops, willing to cooperate, were chosen for the
study;
3. A total of 20 private sector doctors, who were willing
to cooperate for the study and were practicing in the
chosen areas, were chosen and consisted of 4 paediatri-
cians, 3 physicians, 12 general practitioners (GPs), and
1 dermatologist (who was also practicing as GP).
A convenience sample for private sector facilities was
used because many doctors and retail pharmacy shops
do not tolerate continued data collection processes.
Moreover we wanted to include facilities with a suffi-
cient number of patients per day. A good liaison was
maintained with all the participants and their profes-
sional associations, who helped in enrolling the facilities
throughout the study period.
Data collection methodology: Patient exit interviews
Trained data collectors (pharmacists) collected antibiotic
use data by conducting exiting interviews with all
patients receiving/purchasing an antibiotic on leaving
the facility. For private retail pharmacies any patient
purchasing an antibiotic, whether with a prescription,
without a prescription, or on the advice of chemist, was
interviewed. For public sector facilities and private
clinics all the patients interviewed were out-patients. In
private facilities, exiting patient interviews were con-
ducted in a part of the waiting room after the patient
had left the consultation room. In pharmacies, exiting
patient interviews were conducted in a part of the shop
or on the street outside. At public facilities, exit inter-
views were conducted near the pharmacy of the same
facility. A pre-designed proforma was used to collect
data regarding the name of the antibiotic, the strength,
the dose and the number of units prescribed by the doc-
tor, and the number of units dispensed or purchased.
Sample size
30 exit interviews were conducted in each public sector
facility and private retail pharmacy in each month. How-
ever, only about 10-12 exit interviews were conducted in
each private clinic every month as the patient flow was
m u c hl e s sa n di tw a sn o tp o s s i b l et ow a i tt h er e q u i r e d
time to collect the same number of patients due to
resource constraints. The rationale for conducting this
number of exit interviews is from the WHO manual,
“How to investigate drug use in health facilities” which
recommends 600 encounters (20 facilities and 30
patients/prescriptions per facility) for one survey [10].
Data collectors’ schedules were randomly prepared for
the day and time (two hour) of each visit. During each
facility visit, all patients receiving any antibiotic were
interviewed. Also, the total number of patients visiting
each facility (whether or not they received antibiotics)
during the time taken to collect the desired number of
antibiotic-containing prescriptions was counted by a
second data collector and recorded at each visit. Data
were collected monthly from the same facilities in all
three types of facility throughout the study period. Each
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the required number of exit interviews/prescriptions.
Outcome measures
The Anatomical Therapeutic Chemical (ATC) classifica-
tion and the Defined Daily Dose (DDD), ATC/DDD
(2006), measurement units were assigned to the data
[11]. Consumption of antibiotics was expressed in two
ways - the total number of DDDs/1000 patients attend-
ing the facility and the percentage of patients receiving
an antibiotic. To calculate the total DDDs for each exit
interview, the strength of dosage form (tablet/capsule
etc.) was multiplied by the total units (number of
tablets/capsules) of each antibiotic received and the
resulting figure then divided by the DDD of that anti-
biotic to give the total DDDs that the patient received.
Antibiotics for local use, like creams and drops, were
not included for calculating the DDDs consumed. The
denominator for exit interview data was the number of
patients attending the facilities (whether or not they
received antibiotics) during the time taken to do the tar-
get number of exit interviews for patients receiving anti-
biotics. Consumption in terms of DDDs per population
per day was not used since complete data (covering all
patient attendees) could not be collected from any facil-
ity nor could all private facilities in the concerned areas
be included.
Data management
All the data collected was entered into software devel-
oped in Visual Basic, SQL Server and Crystal Reports.
The same software was used to analyse the data.
Ethical Approval
Ethical approval for the study was obtained from Val-
labhbhai Patel Chest Institute, University of Delhi, India
and also from WHO Ethics Review Committee. Informed
consent was obtained from all participants and facilities
involved in the study.
Results
Antibiotic Use in the Community in Different Sectors
In enrolled private retail pharmacies, 7101 patients
(39.5%) out of 17995 patients visiting the pharmacies
during data collection purchased an antibiotic (and were
thus interviewed). In enrolled public facilities, 3615
(39.3%) out of 9205 patients were prescribed an antibio-
tic. In enrolled private clinics, 2571 (43.4%) out of 5922
patients were prescribed an antibiotic.
Annual use and consumption of antibiotic
Table 1 shows annual use measured as the percent of
prescriptions containing the major classes of antibiotics
by facility type in the four areas surveyed. In private retail
pharmacies and at private clinics, cephalosporins
(J01DA) and fluoroquinolones (J01MA) were the most
prescribed antibiotic class, followed by the penicillins
(J01C), while the older antibiotics such as cotrimoxazole
(J01EE01) and the tetracyclines (J01A), were infrequently
used. By contrast, in public sector facilities, all the groups
of antibiotics were used - penicillins (10.2%), fluroquino-
lones (9.0%), macrolides (6.6%), cephalosporins (5.7%,)
cotrimoxazole (4.4%) and tetracyclines (3.4%) - in all the
areas surveyed.
Table 2 shows annual consumption of various classes of
antibiotics measured as DDD/1000 patients by facility
type. Consumption measured in terms of DDD/1000
patients showed similar trends as when measured in terms
of percentage of patients receiving an antibiotic. Thus, for
both private pharmacies and private clinics, highest con-
sumption was for the fluoroquinolones, closely followed
by the cephalosporins and the penicillins. In the public
sector, highest consumption was of penicillins and fluoro-
quinolones, followed by the macrolides, tetracyclines, and
cephalosporins. Macrolides (J01FA) and tetracyclines were
not consumed in large quantities in the private sector.
Cotrimoxazole was the least consumed antimicrobial in
both the public and private sectors (Table 2). The pattern
of consumption of various groups of the antibiotics
appeared similar in all the four areas studied.
Pattern of consumption of members from different
classes of antibiotics
Table 2 shows the top three most commonly prescribed
members from each class of antibiotic and the percentage
for each of these antibiotics out of the total DDDs/1000
patients’ consumption of all antibiotics. Patterns of use in
Table 1 Percent of prescriptions with various classes of
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were similar. Newer antibiotics were often used more than
the older ones. Thus, cefuroxime, cefixime and cefixime
+clavulanic acid were the most commonly prescribed
cephalosporins and ofloxacin, ciprofloxacin, levofloxacin,
and norfloxacin were the most commonly prescribed
fluoroquinolones. For penicillins, only the extended spec-
trum penicillins were prescribed, viz. amoxicillin+clavula-
nic acid, amoxicillin, and amoxicillin+cloxacillin. For
macrolides, roxithromycin and azithromycin were pre-
scribed/purchased more than erythromycin.
At public facilities, while the newer members from
each class of antibiotic were also used, there was more
use of the older antibiotics than in the private sector.
Thus, newer antibiotics such as cefuroxime, ofloxacin,
and roxithromycin were commonly used as in the
private sector but older antibiotics such as cephalexin,
erythromycin, cotrimoxazole, and tetracyclines were also
commonly used. However, older antibiotics were used
sparingly in the private sector (Table 2). For penicillins,
in the public sector, the highest prescribed member was
amoxicillin followed by amoxicillin+clavulanic acid and
Table 2 Antibiotic use (DDD/ 1000 patients) in the facilities surveyed in Delhi, India (December 2007-November 2008)
Antibiotic name Public sector Private retail Private clinic
DDD %* DDD %* DDD %*
Cephalosporins J01DA
Cefuroxime 3132 7.2% 13511 10.8% 8987 11.0%
Cephalexin 971 2.2%
Cefixime - 8065 6.4% 5919 7.3%
Cefixime + clavulanic acid - 4127 3.3% 2897 3.5%
Others 31 7256 3635
Subtotal 4134 32959 21929
Fluoroquinolones J01MA
Ofloxacin 5516 12.7% 15652 12.5% 13222 16.2%
Ciprofloxacin 4367 10.1% 7557 6.0% 5434 6.7%
Levofloxacin - 5559 4.4% 4586 5.6%
Norfloxacin 2590 6.0% 3332 2.6% 1028 1.3%
Others 86 5639 2750
Subtotal 12559 37739 27020
Penicillins J01C
Amoxicillin 6403 14.7% 8240 6.6% 2263 2.8%
Amoxicillin+Calvulinic acid 2873 6.6% 16299 13.0% 14370 17.6%
Amoxicillin+Cloxacillin - 4082 3.2% 3065 3.8%
Ampicillin 2234 5.1%
Others 1078 1859 148
Subtotal 12588 30480 19846
Macrolides J01FA
Roxithromycin 3995 9.2% 6836 5.4% 3353 4.1%
Azithromycin 38 0.09% 5404 4.3% 3648 4.5%
Erythromycin 2286 5.3% 2535 2.0% 292 0.3%
Others 0 801 719
Subtotal 6319 15576 8012
Tetracycline J01A
Doxicycline 4210 9.7% 6147 4.9% 4440 5.4%
Tetracycline 1759 4.0% 949 0.8% 7 0.008%
Others 15 12 33
Subtotal 5884 7108 4480
Combinations of Sulfonamide with Trimethoprim (J01EE)
Cotriamoxazole 1806 4.0% 1682 1.3% 180 0.2%
Total DDDs/1000 patients for all antibiotics 43390 125544 81467
*% of total DDDs/1000 patients for all antibiotics.
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scribed penicillin was amoxicillin+clavulanic acid and
ampicillin was not prescribed.
Monthly trends in the use of antibiotics
F i g u r e s1 ,2 ,3 ,4 ,5a n d6s h o wt h em o n t h l yt r e n d si n
the percent of prescriptions containing various classes of
antibiotics in the three types of facility surveyed as well
as the average consumption (across all facility types) of
each antibiotic group over a year. Although there were
no marked differences in the consumption of each parti-
cular antibiotic class throughout the year, there did
appear to be some overall increased use of macrolides,
tetracyclines, cotrimoxazole and penicillins (commonly
used for acute respiratory tract infection) during the
winter months December-March. By contrast, the use of
fluroquinolones (commonly used for diarrhea) appeared
greatest during the rainy months of summer, July-
August. (Figure 2).
Discussion
This is one of the first studies from a developing coun-
try that describes a large, comprehensive surveillance of
antibiotic use in three facility types over a one-year per-
iod to get a complete picture of antibiotic use in an
urban community. There is evidence at the national
level [12] as well as some evidence at the patient level
[13] from Europe that the incidence of resistance is
positively correlated with antibiotic use in the outpati-
ent. Hence, a continuous surveillance of antibiotic use
and resistance plus detailed knowledge of antibiotic use
in the community are necessary to develop and imple-
ment guidelines for antibiotic use in a particular region.
Surveillance of antimicrobial use in the community for
developing countries is difficult because no databases
are available and antibiotics can be purchased over-the-
Figure 1 Monthly use of cephalosporins in the community
from December 2007-November 2008.
Figure 2 Monthly use of fluoroquinolones in the community
from December 2007-November 2008.
Figure 3 Monthly use of penicillins in the community from
December 2007-November 2008.
Figure 4 Monthly use of macrolides in the community from
December 2007-November 2008.
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methodology used can be utilized in any developing
country to collect data on outpatient antibiotic use. In
this study data, on average across three facility types,
41% of patients were prescribed an antibiotic in the
community. Surveillance of antibiotics conducted at two
other sites in India, Vellore and Mumbai, also showed
41% and 42% average consumption of antibiotics,
respectively, across three facility types [9]. Previous drug
utilization studies and prescription audit studies con-
ducted in different cities of India have shown that 39%
of drugs prescribed to outdoor patients in Goa, [16] and
43% in Pune [17] were antibiotics. The data available on
antibiotic use in the community in India, is often frag-
mented, usually being collected over a few months
either for a drug use indicator study or for examining
treatment of a particular disease [18,19].
Measuring the percent of antibiotic containing pre-
scriptions is an easy and more reliable method than
measuring the DDD/1000 inhabitants in these settings
as the data is not collected from all the facilities serving
a population. However, data on DDD consumed per
1000 patients can help in providing insight into how
antibiotics are used [20]. For example, our study clearly
shows that while the proportion of patients receiving
antibiotics is similar in the public and private sectors
(Table1), the total DDDs dispensed at public sector
facilities is much less than in private retail pharmacies
and private clinics (Table 2). This indicates that much
smaller amounts are dispensed per patient in the public
versus the private sector. It was found that in the public
sector antibiotics were dispensed to patients for three
days and, in the case of antibiotic shortages, even fewer
days than this. By contrast, longer courses were dis-
pensed in the private sector. In a few cases the different
drug use measures gave slightly different results with
regard to identifying the most frequently or highest con-
sumed antibiotic. For example, in private retail pharma-
cies, cephalosporins was the most frequently consumed
type of antibiotic, followed by fluoroquinolones, accord-
ing to the percent of patients receiving the antibiotic
(Table 1) but fluoroquinolones followed by cephaolos-
prins according to the measure, DDDs/1000 patients
(Table 2).
The surveillance system was able to track trends and
patterns of antibiotic use in all the types of facilities:
public facilities, private clinics and private retail pharma-
cies. Findings from the present survey clearly show the
importance of tracking antibiotic use in different facility
types as consumption of various classes of antibiotics
was clearly different. In the public sector, almost all
classes of antibiotics were prescribed while in the private
sector virtually only the newer antibiotics were con-
sumed. Comparison of the results of this survey in 2008
with the pilot survey conducted at the private retail
pharmacies in the same areas in 2004 [8] showed that
consumption of macrolides appears to have decreased
while that of cephalosporins appears to have markedly
increased during the period 2004 - 2008. This is worry-
ing from the perspective of increasing resistance to the
cephalosporins. Thus, this repeat survey using the same
methodology in the same areas shows itself to be a good
system of surveillance of antibiotic use, catching trends
and patterns of use over a period of time.
No major differences in the pattern of use of the var-
ious antibiotic groups were found between the four
wards/areas surveyed for any facility types nor were any
major differences found with regard to the percent of
patients receiving antibiotics in four areas surveyed. In
each of the four areas, the percent of patient receiving
an antibiotic was 38%-41% in public facilities and 39%-
41% in private retail pharmacies. However, for private
clinics the percent of patients who received antibiotics
in Rajouri Garden was 34% and in Karol Bagh 38% as
compared to Patel Nagar where it was 56% and Rajinder
Figure 5 Monthly use of cotrimoxazole in the community from
December 2007-November 2008.
Figure 6 Monthly use of tetracyclines in the community from
December 2007-November 2008.
Kotwani and Holloway BMC Infectious Diseases 2011, 11:99
http://www.biomedcentral.com/1471-2334/11/99
Page 6 of 9Nagar where it was 50%. It is difficult to determine the
reasons for this variation but it may be associated with
the general socioeconomic status of the neighbourhoods,
as Patel Nagar and Rajinder Nagar are richer than the
other areas. As we did not study the sociodemographic
profile of the patients visiting the facilities it is not pos-
sible to analyse this further. A study conducted in Uttar
Pradesh, India showed that higher socioeconomic status
of the patients was associated with higher antibiotic use
[21].
A small degree of variation was observed in the pre-
scription of different antibiotics over 12 months. In pub-
lic facilities any variation could have been due to
variation in supply of antibiotics to public health facil-
ities from the main central store (though correlation of
use with availability was not done). Overall there did
appear to be slightly greater use of antibiotics (penicil-
lins, tetracyclines, cotrimoxazole, macrolides) used for
acute respiratory tract infections (ARI) in the winter
months and for antibiotics used for diarrhea (fluoroqui-
nolones) in the humid summer months. A survey con-
ducted simultaneously with this study showed that
number of diarrhea cases did increase during the rainy
summer months and that fluoroquinolones were the
most commonly prescribed antibiotic for diarrhea [22].
It is likely that much of the antibiotic use was inap-
propriate particularly with regard to use of fluoroquino-
lones in the humid summer months for diarrhea. The
European Surveillance of Antimicrobial Consumption
(ESAC) study has shown a higher outpatient antibiotic
use in the winter season in all countries. The authors
explained that this seasonal variation could be related to
an increased incidence of respiratory tract infections
during the winter months in European countries, result-
ing in higher prescription rates during this period [23].
Acute respiratory infections are more likely in the win-
ter months in Delhi also and it is likely that the slightly
higher consumption of some antibiotics during the win-
ter months in our study was due to this and could
include inappropriate prescribing for coughs and colds.
The high and increasing use of the newer antibiotics in
the community is worrying, as such antibiotics may often
not be needed and their use will lead to resistance in the
treatment of serious infections. The older antibiotics
should be sufficient for many of the common infections
seen in the community. While there is a profit-motive in
the private sector for using the newer and more expensive
antibiotics, the reason for their increased use in the public
sector is not clear. There is an essential medicine list
(EML) for all public facilities under the Government of
National Capital Territory of Delhi, and this list is regu-
larly updated and used for procurement of all medicines.
The Delhi state EML has a separate EML for dispensaries
and this list has antibiotics, like amoxicillin, ampicillin,
ciprofloxacin, norfloxacin, cephalexin (for restricted use),
erythromycin, roxithromycin, cotrimoxazole and doxycy-
cline. These antibiotics are the first choice to treat most
common infections in the community. Antibiotics like
ofloxacin and cefuraxime are added to the hospital list of
the EML with an *asterisk indicating that they are reserve
antibiotics to be used only in case of significant resistance
to other antibiotics [24]. However, our survey revealed
that antibiotics for hospital use were available in the dis-
pensaries and were frequently used by the doctors there.
A detailed study should be conducted to find out why the
newer antibiotics reserved for hospital use are being used
in the public dispensaries. It could be due to doctor prefer-
ence or non-availability of first generation antibiotics. The
preference of the private sector to use newer broad-spec-
trum antibiotics has been seen elsewhere. A study con-
ducted in Italy in primary health care showed [25] that
GPs had a tendency to preferentially prescribe wide spec-
trum antibiotics and to use, in many cases, antibiotics that
are rarely of choice in primary health care, such as cepha-
losporins and fluoroquinolones. Outpatient antibiotic use
in 26 countries in Europe has also shown a shift from
the old narrow-spectrum antibiotics to the new broad-
spectrum antibiotics [11].
Our study has successfully captured the pattern of
antibiotic use in the community. We did not measure
DDD/1000 inhabitants as is generally done by studies in
European countries. In our settings this is not an accu-
rate measure of exposure of the population to antibio-
tics because we have not included all the facilities of our
catchment area and complete data (covering all patient
attendees) could not be collected from any enrolled
facility. The objective was not to measure accurately
population exposure to antibiotics, but rather to mea-
sure trends in use as part of a surveillance system. Pro-
vided the same methodology is used each month, the
same degree of error will occur each month and the
data collected will be sufficient for trend measurement
even though it is not accurate for a one-off exposure
measurement. Since the exit interview data only mea-
sures use in some of the patients attending some of the
health facilities, the total number of DDDs per popula-
tion would be much less than would be the case if all
the facilities were included.
The most important strength of the study is that it
clearly shows that it is possible to collect useful data for
antibiotic use in all types of facility from wherever it is
prescribed/dispensed/purchased, at the individual patient
level in resource-constrained settings. The study has
some inherent weaknesses. Firstly, it was conducted in
four residential localities of one urban area, so generaliza-
tion should be done with caution for the rest of Delhi
and cannot be done for other areas of India. Secondly,
the presence of data collectors may have changed the
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Doctors may have prescribed fewer antibiotics than nor-
mal and retailers may not have dispensed antibiotics
over-the-counter as often as normal. Some of the Haw-
thorn effect may have reduced over the period of one
year, as the health workers got used to the presence of
the data collectors. In public facilities, the bias on doc-
tors’ prescribing may have been less as the data collectors
were in the pharmacy area and doctors were not always
aware which day and time data collectors were visiting.
The reduced sample size of exiting patient interviews in
private sector clinics, due to time and resource con-
straints may have resulted in less accurate estimates of
antibiotic use in this facility type as compared to the
other facility types. However, the year-long duration of
the study should partially compensate for the lesser num-
ber of patients interviewed each month. While the meth-
odology used is simple, reproducible, and feasible for
collecting data from various facilities in the community
over a long period of time, it requires attention to detail
particularly with regard to supervision of data collection,
data management and maintaining good relations with
frequent feedback to participating facilities (in order to
maintain their cooperation).
Conclusion
Antibiotic use is the key driver of antimicrobial resistance.
Antibiotics are overused, particularly for minor infections,
misused for self-limiting viral infections and underused
due to financial concerns. Extensive surveillance pro-
grammes have been used to study patterns of antibiotic
resistance and use in developed countries. These systems
have made it possible to stimulate the implementation of
nationwide interventions to improve antibiotic use [26].
Results from our study have shown that community-based
surveillance of antibiotic use is possible in resource-
constrained settings, and patterns of antibiotic use can be
surveyed over years. The methodology can collect useful
data that reveal trends and patterns of antibiotic use in the
community. However, the effort of collecting such data is
only worthwhile if policy makers invest in the interven-
tions urgently needed to improve the use of antibiotics
in the community and to contain antibiotic resistance.
Without such action, increasing antimicrobial resistance
will deny future generations the benefit of effective anti-
biotics to treat common infections.
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